{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:17:51Z","timestamp":1783631871457,"version":"3.55.0"},"reference-count":131,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Migraine course is influenced by female reproductive milestones, including menstruation and perimenopause; menstrual migraine (MM) represents a distinct clinical entity. Increased susceptibility to migraine during menstruation and in perimenopause is probably due to fluctuations in estrogen levels. The present review provides suggestions for the treatment of MM and perimenopausal migraine. MM is characterized by long, severe, and poorly treatable headaches, for which the use of long-acting triptans and\/or combined treatment with triptans and common analgesics is advisable. Short-term prophylaxis with triptans and\/or estrogen treatment is another viable option in women with regular menstrual cycles or treated with combined hormonal contraceptives; conventional prevention may also be considered depending on the attack-related disability and the presence of attacks unrelated to menstruation. In women with perimenopausal migraine, hormonal treatments should aim at avoiding estrogen fluctuations. Future research on migraine treatments will benefit from the ascertainment of the interplay between female sex hormones and the mechanisms of migraine pathogenesis, including the calcitonin gene-related peptide pathway.<\/jats:p>","DOI":"10.3390\/jcm10112263","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T12:38:01Z","timestamp":1621859881000},"page":"2263","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Acute and Preventive Management of Migraine during Menstruation and Menopause"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-4031","authenticated-orcid":false,"given":"Raffaele","family":"Ornello","sequence":"first","affiliation":[{"name":"Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"De Matteis","sequence":"additional","affiliation":[{"name":"Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-3168","authenticated-orcid":false,"given":"Chiara","family":"Di Felice","sequence":"additional","affiliation":[{"name":"Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Caponnetto","sequence":"additional","affiliation":[{"name":"Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-4240","authenticated-orcid":false,"given":"Francesca","family":"Pistoia","sequence":"additional","affiliation":[{"name":"Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-1939","authenticated-orcid":false,"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[{"name":"Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Collaborators","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, Burden, and Comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","article-title":"Migraine remains second among the world\u2019s causes of disability, and first among young women: Findings from GBD2019","volume":"21","author":"Steiner","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1474-4422(20)30482-8","article-title":"Menstrual migraine: A distinct disorder needing greater recognition","volume":"20","author":"Vetvik","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102409355601","article-title":"Migraine prevalence by age and sex in the United States: A life-span study","volume":"30","author":"Victor","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s10194-018-0922-7","article-title":"Male and female sex hormones in primary headaches","volume":"19","author":"Delaruelle","year":"2018","journal-title":"J. Headache Pain."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","article-title":"Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen","volume":"67","author":"MacGregor","year":"2006","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/head.13291","article-title":"Understanding Menstrual Migraine","volume":"58","author":"Calhoun","year":"2018","journal-title":"Headache"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2147\/IJWH.S70073","article-title":"Migraine in menopausal women: A systematic review","volume":"7","author":"Sacco","year":"2015","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_10","first-page":"435","article-title":"Gender aspects of CGRP in migraine","volume":"39","author":"MaassenVanDenBrink","year":"2017","journal-title":"Cephalalgia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s10194-020-01197-0","article-title":"Estrogen receptors \u03b1, \u03b2 and GPER in the CNS and trigeminal system-molecular and functional aspects","volume":"21","author":"Warfvinge","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rossetti, M.F., Cambiasso, M.J., Holschbach, M.A., and Cabrera, R. (2016). Oestrogens and Progestagens: Synthesis and Action in the Brain. J. Neuroendocr., 28.","DOI":"10.1111\/jne.12402"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.yfrne.2013.06.001","article-title":"Estrogenic influences in pain processing","volume":"34","author":"Amandusson","year":"2013","journal-title":"Front. Neuroendocr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/head.13082","article-title":"Oxytocin and Migraine Headache","volume":"57","author":"Tzabazis","year":"2017","journal-title":"Headache: J. Head Face Pain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5214\/ans.0972.7531.190403","article-title":"Effects of Estrogen on the Serotonergic System and Calcitonin Gene-Related Peptide in Trigeminal Ganglia of Rats","volume":"19","author":"Aggarwal","year":"2012","journal-title":"Ann. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0333102415618615","article-title":"Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders","volume":"36","author":"Tzabazis","year":"2016","journal-title":"Cephalalgia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnint.2020.00026","article-title":"Progesterone and Allopregnanolone Rapidly Attenuate Estrogen-Associated Mechanical Allodynia in Rats with Persistent Temporomandibular Joint Inflammation","volume":"14","author":"Hornung","year":"2020","journal-title":"Front. Integr. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","author":"Olesen","year":"2018","journal-title":"Cephalalgia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1468-2982.2003.00516.x","article-title":"Menstrual Migraine in A Representative Dutch Population Sample: Prevalence, Disability and Treatment","volume":"23","author":"Couturier","year":"2003","journal-title":"Cephalalgia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0333102413507637","article-title":"Prevalence of menstrual migraine: A population-based study","volume":"34","author":"Vetvik","year":"2013","journal-title":"Cephalalgia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1468-2982.2004.00741.x","article-title":"Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres","volume":"24","author":"Granella","year":"2004","journal-title":"Cephalalgia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1526-4610.2010.01625.x","article-title":"Characteristics of Menstrual vs Nonmenstrual Migraine: A Post Hoc, Within-Woman Analysis of the Usual-Care Phase of a Nonrandomized Menstrual Migraine Clinical Trial","volume":"50","author":"MacGregor","year":"2010","journal-title":"Headache J. Head Face Pain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/0333102415575723","article-title":"Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine","volume":"35","author":"Vetvik","year":"2015","journal-title":"Cephalalgia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s13760-017-0802-y","article-title":"Clinical characteristics of menstrually related and non-menstrual migraine","volume":"117","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10194-007-0361-3","article-title":"Cephalalgiaphobia: A possible specific phobia of illness","volume":"8","author":"Peres","year":"2007","journal-title":"J. Headache Pain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1129-2377-14-49","article-title":"Cephalalgiaphobia as a feature of high-frequency migraine: A pilot study","volume":"14","author":"Giannini","year":"2013","journal-title":"J. Headache Pain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/head.12763","article-title":"Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study","volume":"56","author":"Martin","year":"2016","journal-title":"Headache J. Head Face Pain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2003.03092.x","article-title":"Migraine prevalence during menopausal transition","volume":"43","author":"Wang","year":"2003","journal-title":"Headache"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0333102416653234","article-title":"Changes in migraine before and after menopause in Japanese climacteric women","volume":"37","author":"Makita","year":"2017","journal-title":"Cephalalgia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000336838","article-title":"Headaches in Middle-Aged Women during Menopausal Transition: A Headache Clinic-Based Study","volume":"68","author":"Oh","year":"2012","journal-title":"Eur. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0733-8619(05)70299-1","article-title":"Menstruation, Sex Hormones, and Migraine","volume":"15","author":"MacGregor","year":"1997","journal-title":"Neurol. Clin."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2147\/NDT.S285863","article-title":"Patterns of Migraine in Postmenopausal Women: A Systematic Review","volume":"17","author":"Ornello","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10194-005-0156-3","article-title":"Managing migraine headaches experienced by patients who self-report with menstrually related migraine: A prospective, placebo-controlled study with oral sumatriptan","volume":"6","author":"Dowson","year":"2005","journal-title":"J. Headache Pain"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1368-5031.2004.00295.x","article-title":"Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine","volume":"58","author":"Landy","year":"2004","journal-title":"Int. J. Clin. Pr."},{"key":"ref_35","first-page":"835","article-title":"Pain-Free Efficacy after Treatment with Sumatriptan in the Mild Pain Phase of Menstrually Associated Migraine","volume":"102","author":"Nett","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/jwh.2008.1031","article-title":"Frovatriptan for Acute Treatment of Migraine Associated with Menstruation: Results from an Open-Label Postmarketing Surveillance Study","volume":"18","author":"Newman","year":"2009","journal-title":"J. Women\u2019s Health"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1468-1331.2005.01076.x","article-title":"Efficacy of oral naratriptan in the treatment of menstrually related migraine","volume":"12","author":"Massiou","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1526-4610.2004.04027.x","article-title":"Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: A randomized, prospective, parallel-group, double-blind, placebo-controlled study","volume":"44","author":"Loder","year":"2004","journal-title":"Headache"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0333102410378048","article-title":"Almotriptan 12.5 mg in menstrually related migraine: A randomized, double-blind, placebo-controlled study","volume":"31","author":"Allais","year":"2011","journal-title":"Cephalalgia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s10072-012-1044-7","article-title":"Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: Pooled analysis of three double-blind, randomized, crossover, multicenter studies","volume":"33","author":"Allais","year":"2012","journal-title":"Neurol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10194-012-0455-4","article-title":"Frovatriptan versus almotriptan for acute treatment of menstrual migraine: Analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study","volume":"13","author":"Bartolini","year":"2012","journal-title":"J. Headache Pain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10194-011-0366-9","article-title":"Efficacy of frovatriptan in the acute treatment of menstrually related migraine: Analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan","volume":"12","author":"Savi","year":"2011","journal-title":"J. Headache Pain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1526-4610.2010.01657.x","article-title":"Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea","volume":"50","author":"Durham","year":"2010","journal-title":"Headache"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/jwh.2007.0440","article-title":"Menstrual-Related Pain Conditions: Dysmenorrhea and Migraine","volume":"17","author":"Mannix","year":"2008","journal-title":"J. Women\u2019s Health"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0333102412451360","article-title":"Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura","volume":"32","author":"Antonova","year":"2012","journal-title":"Cephalalgia"},{"key":"ref_46","first-page":"176","article-title":"Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: Double-blind study with placebo","volume":"5","year":"2000","journal-title":"Eur. J. Med. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"Am. J Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/09513590.2010.487607","article-title":"Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: A pilot study","volume":"26","author":"Facchinetti","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1586\/ern.11.123","article-title":"Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea","volume":"11","author":"Allais","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1526-4610.2011.01894.x","article-title":"Sumatriptan-Naproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes","volume":"51","author":"Cady","year":"2011","journal-title":"Headache"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jwh.2013.4577","article-title":"Relief of Menstrual Symptoms and Migraine with a Single-Tablet Formulation of Sumatriptan and Naproxen Sodium","volume":"23","author":"Martin","year":"2014","journal-title":"J. Women\u2019s Health"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","article-title":"Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: Two randomized controlled trials","volume":"114","author":"Mannix","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0333102414542290","article-title":"Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial","volume":"35","author":"Allais","year":"2014","journal-title":"Cephalalgia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s10194-015-0510-z","article-title":"Migraine and body mass index categories: A systematic review and meta-analysis of observational studies","volume":"16","author":"Ornello","year":"2015","journal-title":"J. Headache Pain"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/WNL.0000000000003919","article-title":"Body composition status and the risk of migraine: A meta-analysis","volume":"88","author":"Gelaye","year":"2017","journal-title":"Neurology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/WNL.0b013e3182a824f7","article-title":"Episodic migraine and obesity and the influence of age, race, and sex","volume":"81","author":"Peterlin","year":"2013","journal-title":"Neurology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/head.12788","article-title":"Adipokines and Migraine: A Systematic Review","volume":"56","author":"Peterlin","year":"2016","journal-title":"Headache"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/humupd\/dmw045","article-title":"Ovarian hormones and obesity","volume":"23","author":"Leeners","year":"2017","journal-title":"Hum. Reprod. Update"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0333102410378049","article-title":"Perimenstrual migraines and their response to preventive therapy with topiramate","volume":"31","author":"Allais","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s10194-020-01167-6","article-title":"Efficacy and safety of erenumab in women with a history of menstrual migraine","volume":"21","author":"Pavlovic","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ornello, R., Frattale, I., Caponnetto, V., De Matteis, E., Pistoia, F., and Sacco, S. (2021). Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series. Brain Sci., 11.","DOI":"10.3390\/brainsci11030370"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/CON.0000000000000635","article-title":"Preventive Therapy of Migraine","volume":"24","author":"Schwedt","year":"2018","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11916-008-0079-1","article-title":"Perimenstrual headaches: Unmet needs","volume":"12","author":"MacGregor","year":"2008","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1526-4610.1990.hed3011705.x","article-title":"Naproxen sodium in menstrual migraine prophylaxis: A double-blind placebo controlled study","volume":"30","author":"Sances","year":"1990","journal-title":"Headache"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2165\/00003495-199300461-00031","article-title":"Nimesulide in the Treatment of Menstrual Migraine","volume":"46","author":"Giacovazzo","year":"1993","journal-title":"Drugs"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1468-2982.2009.01840.x","article-title":"Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks","volume":"29","author":"Brandes","year":"2009","journal-title":"Cephalalgia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1526-4610.2009.01513.x","article-title":"Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis","volume":"49","author":"MacGregor","year":"2009","journal-title":"Headache J. Head Face Pain"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","article-title":"A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine","volume":"63","author":"Silberstein","year":"2004","journal-title":"Neurology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1526-4610.2007.00855.x","article-title":"Efficacy and Tolerability of Naratriptan for Short-Term Prevention of Menstrually Related Migraine: Data from Two Randomized, Double-Blind, Placebo-Controlled Studies","volume":"47","author":"Mannix","year":"2007","journal-title":"Headache J. Head Face Pain"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1526-4610.2001.111006248.x","article-title":"Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, double-blind, placebo-controlled study","volume":"41","author":"Newman","year":"2001","journal-title":"Headache"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200822100-00007","article-title":"Oral zolmitriptan in the short-term prevention of menstrual migraine: A randomized, placebo-controlled study","volume":"22","author":"Tuchman","year":"2008","journal-title":"CNS Drugs"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1517\/14656566.2014.947959","article-title":"Menstrual migraine: An updated review on hormonal causes, prophylaxis and treatment","volume":"15","author":"Silberstein","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s10194-018-0896-5","article-title":"Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)","volume":"19","author":"Sacco","year":"2018","journal-title":"J. Headache Pain"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.SMJ.0000129924.15619.D9","article-title":"A Novel Specific Prophylaxis for Menstrual-associated Migraine","volume":"97","author":"Calhoun","year":"2004","journal-title":"South Med. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1136\/bmj.293.6561.1540","article-title":"Prevention of menstrual migraine by percutaneous oestradiol","volume":"293","author":"Vincens","year":"1986","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09513598809023619","article-title":"Menstrual migraine: A double-blind trial of percutaneous estradiol","volume":"2","author":"Dennerstein","year":"1988","journal-title":"Gynecol. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","article-title":"Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study","volume":"67","author":"MacGregor","year":"2006","journal-title":"Neurology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1526-4610.1994.hed3402103.x","article-title":"Perimenstrual Migraine: Effect of Estraderm TTS(r) and the Value of Contingent Negative Variation and Exteroceptive Temporalis Muscle Suppression Test","volume":"34","author":"Smits","year":"1994","journal-title":"Headache"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.fertnstert.2011.05.089","article-title":"Prevention of menstrual migraine with perimenstrual transdermal 17-\u03b2-estradiol: A randomized, placebo-controlled, double-blind crossover study","volume":"96","author":"Hammar","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.contraception.2013.02.001","article-title":"Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM)","volume":"88","author":"Nappi","year":"2013","journal-title":"Contracept"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/11586720-000000000-00000","article-title":"Extended cycles with the combined oral contraceptive chlormadinone acetate 2\u2009mg\/ethinylestradiol 0.03\u2009mg: Pooled analysis of data from three large-scale, non-interventional, observational studies","volume":"31","author":"Schramm","year":"2011","journal-title":"Clin. Drug Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bmjsrh-2017-200036","article-title":"The 7-day contraceptive hormone-free interval should be consigned to history","volume":"44","author":"MacGregor","year":"2018","journal-title":"BMJ Sex. Reprod. Health"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1526-4610.2012.02211.x","article-title":"The Impact of Extended-Cycle Vaginal Ring Contraception on Migraine Aura: A Retrospective Case Series","volume":"52","author":"Calhoun","year":"2012","journal-title":"Headache"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0753-3322(02)00181-6","article-title":"Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine","volume":"56","author":"Burke","year":"2002","journal-title":"Biomed. Pharmacother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002826-200405000-00010","article-title":"Phyto-oestrogens in the Prophylaxis of Menstrual Migraine","volume":"27","author":"Ferrante","year":"2004","journal-title":"Clin. Neuropharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2015.04.021","article-title":"Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies","volume":"136","author":"Xu","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_87","first-page":"1","article-title":"Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: A systematic review and suggestions for future research","volume":"2020","author":"Ornello","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1468-2982.2000.00112.x","article-title":"Migraine with aura and reproductive life events: A case control study","volume":"20","author":"Granella","year":"2000","journal-title":"Cephalalgia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1474-4422(04)00768-9","article-title":"Oestrogen and attacks of migraine with and without aura","volume":"3","author":"MMacGregor","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"114109","DOI":"10.18632\/oncotarget.23141","article-title":"17-\u03b2-Estradiol induces spreading depression and pain behavior in alert female rats","volume":"8","author":"Sandweiss","year":"2017","journal-title":"Oncotarget"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s10194-017-0815-1","article-title":"Hormonal contraceptives and risk of ischemic stroke in women with migraine: A consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)","volume":"18","author":"Sacco","year":"2017","journal-title":"J. Headache Pain"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1526-4610.2003.03065.x","article-title":"Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache","volume":"43","author":"Martin","year":"2003","journal-title":"Headache: J. Head Face Pain"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1526-4610.1991.hed3105298.x","article-title":"Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium","volume":"31","author":"Facchinetti","year":"1991","journal-title":"Headache"},{"key":"ref_94","first-page":"CR16-9","article-title":"The effect of vitamin E on the treatment of menstrual migraine","volume":"15","author":"Ziaei","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10072-012-1054-5","article-title":"Premenstrual syndrome and migraine","volume":"33","author":"Allais","year":"2012","journal-title":"Neurol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13760-012-0111-4","article-title":"Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: An open-label clinical observation","volume":"113","author":"Ambrosini","year":"2012","journal-title":"Acta Neurol. Belg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2015.05.009","article-title":"Prophylactic treatment in menstrual migraine: A proof-of-concept study","volume":"354","author":"Wickmann","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/gme.0b013e31824d8f40","article-title":"Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging","volume":"19","author":"Harlow","year":"2012","journal-title":"Menopause"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1590\/0004-282x20160153","article-title":"Migraine in the post-menopausal period is associated with higher levels of mood disorders, disability, and more menopausal symptoms","volume":"74","author":"Carturan","year":"2016","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline","volume":"100","author":"Stuenkel","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2053369120957514","article-title":"The British Menopause Society & Women\u2019s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women","volume":"26","author":"Hamoda","year":"2020","journal-title":"Post Reprod. Health"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/154099903322643956","article-title":"Postmenopausal hormone therapy and migraine headache","volume":"12","author":"Misakian","year":"2003","journal-title":"J. Women\u2019s Health"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-1331.2006.01557.x","article-title":"Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study","volume":"14","author":"Aegidius","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1046\/j.1526-4610.2002.02215.x","article-title":"Hormone Supplementation Differently Affects Migraine in Postmenopausal Women","volume":"42","author":"Facchinetti","year":"2002","journal-title":"Headache J. Head Face Pain"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-5122(00)00215-2","article-title":"Course of primary headaches during hormone replacement therapy","volume":"38","author":"Nappi","year":"2001","journal-title":"Maturitas"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.gme.0000227399.53192.f5","article-title":"Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches","volume":"13","author":"Nappi","year":"2006","journal-title":"Menopause"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/13697137.2014.966241","article-title":"Efficacy of phytoestrogens for menopausal symptoms: A meta-analysis and systematic review","volume":"18","author":"Chen","year":"2015","journal-title":"Climacteric"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1526-4610.1999.3909674.x","article-title":"Estrogen replacement and migraine aura","volume":"39","author":"MacGregor","year":"1999","journal-title":"Headache J. Head Face Pain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1212\/WNL.41.6.786","article-title":"Estrogens, progestins, and headache","volume":"41","author":"Silberstein","year":"1991","journal-title":"Neurology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/3.2.159","article-title":"Progestogen intolerance and compliance with hormone replacement therapy in menopausal women","volume":"3","author":"Panay","year":"1997","journal-title":"Hum. Reprod. Update"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1258\/mi.2009.009022","article-title":"Hormonal management of migraine at menopause","volume":"15","author":"Nappi","year":"2009","journal-title":"Menopause Int."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10194-008-0048-4","article-title":"Comorbid neuropathologies in migraine: An update on cerebrovascular and cardiovascular aspects","volume":"9","author":"Sacco","year":"2008","journal-title":"J. Headache Pain"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10194-012-0424-y","article-title":"Migraine in women: The role of hormones and their impact on vascular diseases","volume":"13","author":"Sacco","year":"2012","journal-title":"J. Headache Pain"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"North American Menopause Society (2015). Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause, 22, 1155\u20131172.","DOI":"10.1097\/GME.0000000000000546"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2053369117731172","article-title":"Migraine, menopause and hormone replacement therapy","volume":"24","author":"MacGregor","year":"2017","journal-title":"Post Reprod. Health"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2014.1891","article-title":"Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: A randomized clinical trial","volume":"174","author":"Joffe","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","article-title":"The efficacy and safety of venlafaxine in the prophylaxis of migraine","volume":"45","author":"Ozyalcin","year":"2005","journal-title":"Headache"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3988\/jcn.2006.2.4.246","article-title":"The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect","volume":"2","author":"Park","year":"2006","journal-title":"J. Clin. Neurol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/WNF.0b013e3181a8c84f","article-title":"Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders","volume":"32","author":"Tarlaci","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"ref_120","first-page":"CD010609","article-title":"Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults","volume":"2013","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.2010.2016","article-title":"Efficacy of escitalopram for hot flashes in healthy menopausal women: A randomized controlled trial","volume":"305","author":"Freeman","year":"2011","journal-title":"JAMA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/gme.0b013e3180dca175","article-title":"Gabapentin for the treatment of menopausal hot flashes: A randomized controlled trial","volume":"15","author":"Butt","year":"2008","journal-title":"Menopause"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1056\/NEJMp1402080","article-title":"FDA Approval of Paroxetine for Menopausal Hot Flushes","volume":"370","author":"Orleans","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11940-018-0492-7","article-title":"Current Treatment Options: Headache Related to Menopause-Diagnosis and Management","volume":"20","author":"Lauritsen","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_125","first-page":"1","article-title":"Targeting CGRP for migraine treatment: Mechanisms, antibodies, small molecules, perspectives","volume":"2","author":"Guglielmetti","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: A randomised, phase 3, double-blind, placebo-controlled trial","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","article-title":"Oral rimegepant for preventive treatment of migraine: A phase 2\/3, randomised, double-blind, placebo-controlled trial","volume":"397","author":"Croop","year":"2021","journal-title":"Lancet"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1811090","article-title":"Rimegepant, an Oral Calcitonin Gene\u2013Related Peptide Receptor Antagonist, for Migraine","volume":"381","author":"Lipton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0333102415584308","article-title":"Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine","volume":"36","author":"Ho","year":"2016","journal-title":"Cephalalgia"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awz134","article-title":"Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine","volume":"142","author":"Goadsby","year":"2019","journal-title":"Brain"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1212\/WNL.0000000000006641","article-title":"Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study","volume":"91","author":"Kuca","year":"2018","journal-title":"Neurology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/11\/2263\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:06:35Z","timestamp":1760162795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/11\/2263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":131,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jcm10112263"],"URL":"https:\/\/doi.org\/10.3390\/jcm10112263","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]}}}